about
What is meso-zeaxanthin, and where does it come from?Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular diseaseEffect on refractive outcomes after cataract surgery of intraocular lens constant personalization using the Haigis formula.Risk factors for age-related maculopathyAugmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition.Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.The impact of macular pigment augmentation on visual performance using different carotenoid formulations.Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degenerationQuantification of zeaxanthin stereoisomers and lutein in trout flesh using chiral high-performance liquid chromatography-diode array detectionMeasuring Visual Function Using the MultiQuity System: Comparison with an Established DeviceConcordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance.Verification of Meso-Zeaxanthin in Fish.Visual perceptions induced by intravitreous injections of therapeutic agents.A novel index for predicting intraocular pressure reduction following cataract surgery.Macular pigment levels following successful macular hole surgery.Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin.Prevalence of age-related macular degeneration in the Republic of Ireland.The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.Lutein, zeaxanthin and meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified xanthophyllsAssessment of lutein, zeaxanthin and meso-zeaxanthin concentrations in dietary supplements by chiral high-performance liquid chromatographyCognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent CarotenoidsTransport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration.The rationale and evidence base for a protective role of macular pigment in age-related maculopathy.Psychophysical function in age-related maculopathy.Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids.Relationship between macular pigment and visual function in subjects with early age-related macular degeneration.Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT)The evidence informing the surgeon's selection of intraocular lens on the basis of light transmittance properties.Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular DegenerationNon-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population.Concordance of Macular Pigment Measurement Using Customized Heterochromatic Flicker Photometry and Fundus Autofluorescence in Age-Related Macular Degeneration.Determinants of patient satisfaction and function related to vision following cataract surgery in eyes with no visually consequential ocular co-morbidity.Phospholipid oxidation and carotenoid supplementation in Alzheimer's disease patients.Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab.Macular pigment and its contribution to vision.
P50
Q28291367-6D0CFFD8-C920-4B16-B3D3-928F98C76951Q30693939-C9C226B6-3A88-4C9D-B8D0-13D3A6F7CC96Q33627201-F08F3C80-A26E-47F7-917F-285C1E74B69BQ33720834-8AC0A08C-67F6-458C-BCF7-30E927EB3FDCQ34108927-5CFDC275-106E-4AFA-9AD4-A853EA742CFDQ34195023-04CEC8C7-B1EC-40F0-B659-6982CF4DBFF9Q34278325-2E9357AE-90CC-4B4D-824B-E7422FBABBA4Q34310338-22AC9F37-ABAB-4A2B-A475-F8F3505BE355Q34315578-64AEA581-8716-4ED7-9D3B-C5B37A65850FQ34422484-BC9A39FE-210F-4FBA-A5B9-54E57985B9E1Q34443359-72C4D565-8921-434F-8656-C070F3D13516Q34476425-0EBFA969-C37C-455F-92BB-BBB854E1B391Q34542295-317F01BD-1496-493E-A682-C292EDCB2529Q34793558-95AEEBCB-A5FF-431B-8631-43CC73D423DAQ34979039-CA75CFD0-0BEE-4015-84DD-4AF208F6ADEAQ35112300-613365B8-8B1C-4102-BF33-F9C801085B76Q35208745-8E8C5C33-7FC7-4A19-BEAE-7814073B8592Q35593209-41543BB6-8042-4F53-92C4-0225F6B4B33FQ35593638-A6298558-7E83-4682-A4BB-629228073A7FQ35869691-B1728C0E-9B77-48D7-8AA5-D63E4B128DFDQ35899608-14D0E11F-8E5B-424F-A1D8-FC9E5732C0D7Q36136223-8C710CA6-8070-43BC-8054-DC246BD36C97Q36454134-E9F7C99A-A7DE-460D-9230-9392243AA64EQ36678494-9C6DA526-00ED-4052-8371-EE46B2E44949Q37044220-695B8A78-B4FD-490B-B199-0EAF74D6EF52Q37055765-98174806-BE7F-4121-882B-DA265BB4F77FQ37231317-9CD78BFC-788C-473F-AA8A-458269BA39FEQ37418316-DB145AF4-4CBB-40D6-AE0E-B6D9512E06B2Q37625442-152FD916-EF29-46B5-88FE-91F1A45E4BEDQ37627233-6915078C-D6F2-4A4B-953F-F231EACB1881Q37631347-A821AFC7-5F89-48E8-AA4D-5AEC35B7EC3CQ37639903-E09BCB6F-EA31-4582-A181-94274CA352A1Q37728614-284B5BD9-06C0-4545-B509-18617BA5E317Q38837386-361BD02A-9139-4E53-B35A-12E8130DC96AQ38937657-E84E6026-099D-47EB-8F5B-FC5F97D22DD7Q40155180-A0144E16-F08E-40D6-A5BD-6C60BC099F2FQ40946094-78E1EF47-650D-4635-B5E7-DEB1D4ACA115Q41014821-F09A1F9B-B4DC-41DF-9CEF-A210708A097FQ41206130-5D4D4352-9D05-4047-863F-ECFA7738F047Q41918704-E48E7E4B-BC9B-4EDD-8568-4DA81C51B87B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John M Nolan
@ast
John M Nolan
@en
John M Nolan
@es
John M Nolan
@nl
John M Nolan
@sl
type
label
John M Nolan
@ast
John M Nolan
@en
John M Nolan
@es
John M Nolan
@nl
John M Nolan
@sl
altLabel
Professor John Nolan
@en
prefLabel
John M Nolan
@ast
John M Nolan
@en
John M Nolan
@es
John M Nolan
@nl
John M Nolan
@sl
P1053
N-4921-2014
P106
P21
P31
P3829
P496
0000-0002-5503-7084